» Articles » PMID: 21621345

Comparison of the Effects of Carbon Ion and Photon Irradiation on the Angiogenic Response in Human Lung Adenocarcinoma Cells

Abstract

Purpose: Radiotherapy resistance is a commonly encountered problem in cancer treatment. In this regard, stabilization of endothelial cells and release of angiogenic factors by cancer cells contribute to this problem. In this study, we used human lung adenocarcinoma (A549) cells to compare the effects of carbon ion and X-ray irradiation on the cells' angiogenic response.

Methods And Materials: A549 cells were irradiated with biologically equivalent doses for cell survival of either carbon ions (linear energy transfer, 170 keV/μm; energy of 9.8 MeV/u on target) or X-rays and injected with basement membrane matrix into BALB/c nu/nu mice to generate a plug, allowing quantification of angiogenesis by blood vessel enumeration. The expression of angiogenic factors (VEGF, PlGF, SDF-1, and SCF) was assessed at the mRNA and secreted protein levels by using real-time reverse transcription-PCR and enzyme-linked immunosorbent assay. Signal transduction mediated by stem cell factor (SCF) was assessed by phosphorylation of its receptor c-Kit. For inhibition of SCF/c-Kit signaling, a specific SCF/c-Kit inhibitor (ISCK03) was used.

Results: Irradiation of A549 cells with X-rays (6 Gy) but not carbon ions (2 Gy) resulted in a significant increase in blood vessel density (control, 20.71 ± 1.55; X-ray, 36.44 ± 3.44; carbon ion, 16.33 ± 1.03; number per microscopic field). Concordantly, irradiation with X-rays but not with carbon ions increased the expression of SCF and subsequently caused phosphorylation of c-Kit in endothelial cells. ISCK03 treatment of A549 cells irradiated with X-rays (6 Gy) resulted in a significant decrease in blood vessel density (X-ray, 36.44 ± 3.44; X-ray and ISCK03, 4.33 ± 0.71; number of microscopic field). These data indicate that irradiation of A549 cells with X-rays but not with carbon ions promotes angiogenesis.

Conclusions: The present study provides evidence that SCF is an X-ray-induced mediator of angiogenesis in A549 cells, a phenomenon that could not be observed with carbon ion irradiation. Thus, in this model system evaluating angiogenesis, carbon ion irradiation may have a therapeutic advantage. This observation should be confirmed in orthotopic lung tumor models.

Citing Articles

Irradiation-responsive PRDM10-DT modulates the angiogenic response in human NSCLC cells in an SP1-dependent manner via the miR-663a/TGF-β1 axis.

Huang H, Xu Y, Guo Z, Zhang M, Li W, Song Y J Transl Med. 2025; 23(1):235.

PMID: 40016776 PMC: 11866594. DOI: 10.1186/s12967-025-06273-0.


Organization and operation of multi particle therapy facilities: the Marburg Ion-Beam Therapy Center, Germany (MIT).

Zink K, Baumann K, Theiss U, Subtil F, Lahrmann S, Eberle F Health Technol (Berl). 2024; 14(5):929-938.

PMID: 39219555 PMC: 11358185. DOI: 10.1007/s12553-024-00881-4.


Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer.

Cunningham C, Bolcaen J, Bisio A, Genis A, Strijdom H, Vandevoorde C Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259367 PMC: 9961924. DOI: 10.3390/ph16020219.


Research Progress of Heavy Ion Radiotherapy for Non-Small-Cell Lung Cancer.

Liang S, Zhou G, Hu W Int J Mol Sci. 2022; 23(4).

PMID: 35216430 PMC: 8876478. DOI: 10.3390/ijms23042316.


Physical and Biological Characteristics of Particle Therapy for Oncologists.

Byun H, Han M, Yang K, Kim J, Yoo G, Koom W Cancer Res Treat. 2021; 53(3):611-620.

PMID: 34139805 PMC: 8291193. DOI: 10.4143/crt.2021.066.